E. Coli Testing Market to Reach US$2.1 bn by 2022 due to Globally Rising Spread and High Morbidity Rates of E. Coli Date: 03-01-2017 09:42 PM CET Category: Health & Medicine Press release from: Transparency Market Research - Pharmaceutical
A new Transparency Market Research report states that the global E. coli testing market stood at US$1.2 bn in 2013 .and is predicted to reach US$2.1 bn by 2022. It is expected to expand at a CAGR of 6.58% from 2014 to 2022. The title of the report is, “E.coli Testing (Environmental Testing and Clinical Testing) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022.� Browse the full E.coli Testing Market (Environmental Testing and Clinical Testing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 report at www.transparencymarketresearch.com/e-coli-testing-market.... Escherichia coli (E. coli) are a diverse and large group of bacteria found in the environment, several foods, and intestines of animals and peoplehumans. Although the majority of strains of E. coli aren’t harmful, others can cause intestinal infections. The key symptoms of an E. coli infection include abdominal pain, diarrhea, and kidney failure. People having weakened immune systems, older adults, young children, and pregnant women are at a high risk of developing such complications. The kinds of E. coli that cause diarrhea are transmitted via contaminated food or water or via contact with affected persons or animals. As per the report, the increasing initiatives taken by governments in favor of E. coli tests and the rising spread and high morbidity of E. coli are amongst the prime factors driving the growth of the market for E. coli testing. In addition, the development of drug-resistant species is also having a positive impact on the growth of the market. Polymerase chain reaction (PCR) tests being used for environment water testing has emerged as a key growth opportunity in the market. On the other hand, the soaring prices of enzyme-substrate tests in comparison with separate apparatus tests are inhibiting the growth of the market. In terms of testing method, the report segments the market into clinical testing and environmental testing. The segment of environmental testing is further segmented into membrane filtration (MF), enzyme-substrate methods, and multiple tube fermentation (MTF). On the other hand, the segment of clinical testing is further segmented into enzyme immunoassays (EIA), polymerase chain reaction (PCR) tests, and others. Amongst these, on the basis of revenue, the segment of enzyme
Seite 1 / 3